Growth Metrics

Kestra Medical Technologies (KMTS) Change in Accured Expenses (2024 - 2026)

Kestra Medical Technologies (KMTS) has disclosed Change in Accured Expenses for 3 consecutive years, with $3.7 million as the latest value for Q1 2026.

  • Quarterly Change in Accured Expenses rose 288.98% to $3.7 million in Q1 2026 from the year-ago period, while the trailing twelve-month figure was $6.1 million through Jan 2026, up 56.63% year-over-year, with the annual reading at $4.6 million for FY2025, 1144.47% up from the prior year.
  • Change in Accured Expenses for Q1 2026 was $3.7 million at Kestra Medical Technologies, up from $1.4 million in the prior quarter.
  • The five-year high for Change in Accured Expenses was $3.7 million in Q1 2026, with the low at -$860000.0 in Q3 2025.
  • Average Change in Accured Expenses over 3 years is $1.2 million, with a median of $1.3 million recorded in 2024.
  • The sharpest move saw Change in Accured Expenses plummeted 714.29% in 2025, then skyrocketed 288.98% in 2026.
  • Over 3 years, Change in Accured Expenses stood at $1.6 million in 2024, then decreased by 16.16% to $1.4 million in 2025, then soared by 166.09% to $3.7 million in 2026.
  • According to Business Quant data, Change in Accured Expenses over the past three periods came in at $3.7 million, $1.4 million, and -$860000.0 for Q1 2026, Q4 2025, and Q3 2025 respectively.